SFRP1 is a Wnt antagonist that binds to the frizzle receptors and blocks Wnt protein‐mediated signaling. Aberrant methylation in the SFRP1 gene is associated with lung cancer due to its involvement in tumorigenesis and progression. This evidence concerns the gene SFRP1 and lung carcinoma.